Found: 13
Select item for more details and to access through your institution.
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03006-3
- By:
- Publication type:
- Article
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1199, doi. 10.1007/s40121-024-00968-5
- By:
- Publication type:
- Article
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 485, doi. 10.1007/s40121-021-00576-7
- By:
- Publication type:
- Article
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 9, p. 3501, doi. 10.1007/s10620-024-08512-8
- By:
- Publication type:
- Article
A noteworthy treatment of metastatic small‐cell lung cancer with afatinib, followed by subsequent development of rare metastatic lesions in the ascending and sigmoid colon.
- Published in:
- Cancer Reports, 2020, v. 3, n. 3, p. 1, doi. 10.1002/cnr2.1243
- By:
- Publication type:
- Article
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137852
- By:
- Publication type:
- Article
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1265, doi. 10.1111/liv.14849
- By:
- Publication type:
- Article
Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 8, p. 2247, doi. 10.1111/jgh.15469
- By:
- Publication type:
- Article
Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227424
- By:
- Publication type:
- Article
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
- By:
- Publication type:
- Article
Comparison of clinical, serological and histological findings between non-ulcer dyspepsia patients with and without Helicobacter pylori infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2001, v. 16, n. 3, p. 276
- By:
- Publication type:
- Article
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011
- By:
- Publication type:
- Article
A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C.
- Published in:
- JGH Open, 2022, v. 6, n. 11, p. 782, doi. 10.1002/jgh3.12825
- By:
- Publication type:
- Article